Ventricular Fibrillation During Amiodarone Infusion in a Patient With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: A Case Report
Tiago Luiz Luz Leiria, Augusto Mantovani, Rafael de March Ronsoni, Leonardo Martins Pires, Marcelo Lapa Kruse, Gustavo Glotz de Lima
Abstract
One third of Wolff-Parkinson-White Syndrome (WPW) patients develop atrial fibrillation (AF). Amiodarone is a commonly used drug for AF control in this scenario. The use of amiodarone can lead to Ventricular Fibrillation (VF) in some of these patients. Here we report and discuss a case of a WPW patient who went into cardiac arrest shortly after amiodarone infusion was started.
J Med Cases. 2012;3(5):300-303
doi: https://doi.org/10.4021/jmc700w
Keywords
Ventricular fibrillation; Atrial fibrillation; Wolff-Parkinson-White syndrome; Amiodarone; Procainamide
Full Text:
HTML
PDF